期刊
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
卷 1875, 期 1, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.bbcan.2020.188481
关键词
miRNAs; Docetaxel resistance; Prostate cancer; Drug resistance; Taxane
One of the main challenges in the treatment of metastatic prostate cancer is the development of resistance to docetaxel, the gold standard therapy. Non-coding RNA appears to play a significant role in the processes leading to docetaxel resistance.
One of the main problems with the treatment of metastatic prostate cancer is that, despite an initial positive response, the majority of patients develop resistance and progress. In particular, the resistance to docetaxel, the gold standard therapy for metastatic prostate cancer since 2010, represents one of the main factors responsible for the failure of prostate cancer therapy. According to the present knowledge, different processes contribute to the appearance of docetaxel resistance and non-coding RNA seems to play a relevant role in them. In this review, a comprehensive overview of the miRNA network involved in docetaxel resistance is described, highlighting the pathway/s affected by their activity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据